Ascentage Pharma Group International (AAPG) Other Accumulated Expenses (2023 - 2025)
Historic Other Accumulated Expenses for Ascentage Pharma Group International (AAPG) over the last 3 years, with Q2 2025 value amounting to $34.8 million.
- Ascentage Pharma Group International's Other Accumulated Expenses changed N/A to $34.8 million in Q2 2025 from the same period last year, while for Jun 2025 it was $34.8 million, marking a year-over-year change of. This contributed to the annual value of $35.4 million for FY2024, which is 2076.99% up from last year.
- Ascentage Pharma Group International's Other Accumulated Expenses amounted to $34.8 million in Q2 2025.
- Ascentage Pharma Group International's Other Accumulated Expenses' 5-year high stood at $35.9 million during Q4 2024, with a 5-year trough of $28.7 million in Q4 2023.
- Its 3-year average for Other Accumulated Expenses is $33.2 million, with a median of $34.8 million in 2025.
- The largest annual percentage gain for Ascentage Pharma Group International's Other Accumulated Expenses in the last 5 years was 2503.17% (2024), contrasted with its biggest fall of 2503.17% (2024).
- Ascentage Pharma Group International's Other Accumulated Expenses (Quarter) stood at $28.7 million in 2023, then increased by 25.03% to $35.9 million in 2024, then decreased by 3.13% to $34.8 million in 2025.
- Its Other Accumulated Expenses was $34.8 million in Q2 2025, compared to $35.9 million in Q4 2024 and $28.7 million in Q4 2023.